vaccine
Researchers in the UK have been granted £1.7 million (€1.98 million) to develop a lung cancer vaccine. The "LungVax" they aim to develop would be the world's first vaccine against lung cancer in people at risk of developing it. The technology for the new vaccine will be similar to that used for the Oxford/AstraZeneca vaccine against COVID-19. Cancer cases expected to grow by more than 20% in Europe by 2045 - WHO agencyThe funding will come from Cancer Research UK and the CRIS Cancer Foundation. "Cancer is a disease of our own bodies and it’s hard for the immune system to distinguish between wh...
Euronews (English)
The Czech authorities reported that there were 28 registered cases of whooping cough in the first week of January. That figure now stands at 3,084 – a number not seen since 1963. The highest rate of the illness is among 15 to 19-year-olds, who account for about one-third of the patients. According to Czech Health Minister Vlastimil Válek, the surge is likely attributable to a mix of a resurgence in respiratory diseases as society shifts away from stringent Covid measures, and incomplete immunization among children. Whooping cough is a highly infectious bacterial disease that affects the lungs ...
Euronews (English)
European lawmakers will seek stronger protection for trade secrets of pharmaceutical companies in talks with EU ministers on new compulsory licensing legislation after a plenary vote on their negotiating mandate held this week. New rules were proposed by the European Commission in April to give the bloc a single instrument for compulsory licensing. Negotiations to approve the final legislative text will start once EU ministers will finalise their own amendments to the commission’s proposal. Governments may grant compulsory licenses in exceptional circumstances allowing use of protected inventi...
Euronews (English)
Health officials are investigating whether there's a link between two new RSV vaccines and cases of a rare nervous system disorder in older US adults. The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said on Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added. But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was presented at a meeting of an expert panel that ...
Euronews (English)
Europe is experiencing an “alarming rise” in measles cases, the World Health Organization (WHO) warned on Tuesday, with a more than 30-fold rise across the region in 2023. More than 30,000 measles cases were reported by 40 of the World Health Organization (WHO) European region’s 53 member states between January and October last year, compared to 941 cases in 2022. The increase in the number of cases is compounded by the hospitalisation of 21,000 people and five measles-related deaths. The WHO says this upward trend is expected to continue if urgent measures are not taken to prevent further spr...
Euronews (English)
Cameroon is the first country that will routinely give children a new malaria vaccine as the shots are rolled out in Africa. The campaign due to start on Monday was described by officials as a milestone in the decades-long effort to curb the mosquito-spread disease on the continent, which accounts for 95 per cent of the world’s malaria deaths. "The vaccination will save lives. It will provide major relief to families and the country’s health system," said Aurelia Nguyen, chief programme officer at Gavi, the Vaccine Alliance, which is helping Cameroon secure the vaccines. The Central African co...
Euronews (English)
Washington (AFP) - Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer. Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020. "We think that in some countries the product could be launched under accelerated approval by 2025," he said in an interview. Unlike conventional vaccines, so-called therapeutic vaccines treat rather than prevent a disease. But they also work by training ...
AFP
Washington (AFP) - The United States on Monday approved Covid vaccines with formulations that more closely target currently circulating variants, as infections are once more on the rise. The new approvals relate to updated vaccines produced by Moderna and Pfizer that correspond to an Omicron sublineage. The Food and Drug Administration (FDA) concluded that the benefits of receiving the shots outweighs the risk for those aged six months and up. "Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death," ...
AFP
Washington (AFP) - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies. The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from 32 through 36 weeks of pregnancy, to protect infants from birth through six months, a statement by the Food and Drug Administration said. It is the latest in a succession of medicines recently approved against the common microbe, which causes tens of thousands of hos...
AFP
There is hope for STD patients as a new gonorrhea vaccine has been approved for fast-track review by the Food and Drug Administration (FDA). The experimental Neisseria gonorrhoeae investigational vaccine (NgG), developed by British pharmaceutical company GSK plc, will be the first of its kind as the sexually transmitted disease (STD) has never had any preventive measures against it. “We welcome the FDA’s decision to grant Fast Track designation for our new vaccine candidate against Neisseria gonorrhoeae infection,” said Phil Dormitzer, who is the Global Head of Vaccines R&D at GSK. “With a hi...
uInterview.com
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら